Maryam Oskoui

NMD4C investigator Dr Maryam Oskoui profile picture


Pediatric Neurologist, Neurophysiologist and Epidemiologist, Clinician Scientist and Director of Pediatric Neurology, Montreal Children’s Hospital

Associate Professor, Departments of Pediatrics and Neurology and Neurosurgery, McGill University | Scientist, Research Institute of the McGill University Health Centre

NMD4C Involvement: Pillar 2: Clinical Research

Email Maryam


Dr. Maryam Oskoui is a pediatric neurologist, neurophysiologist and epidemiologist. She is a Clinician Scientist and Director of Pediatric Neurology at the Montreal Children’s Hospital. She is a Senior Clinical Research Scholar of the FRQ-S with a focus in clinical research and clinical trials in pediatric neuromuscular disorders and has contributed to over 100 peer reviewed publications. She is a Principal investigator and SMA lead for INFORM RARE, a Strategy for Patient Oriented Research innovative clinical trial initiative supported by CIHR.


Dr. Oskoui serves as an evidence-based methodologist for the American Academy of Neurology and has contributed to numerous clinical care guidelines. As part of NMD4C, she is developing clinical guidelines through the Knowledge Translation Team. She contributes to the Canadian Neuromuscular community by serving as a member of the Scientific Advisory Committee for Muscular Dystrophy Canada and chairing the Canadian Pediatric Neuromuscular Group and the Canadian Neuromuscular Disease Registry’s Spinal Muscular Atrophy Working Group. She is a Board member for the Association des Neurologues du Quebec.


Dr. Oskoui completed her medical school and pediatric neurology residency at McGill University (Montreal, Canada), neuromuscular clinical and research fellowship at Columbia University (New York, USA) and Master’s of Science in Clinical Epidemiology at McGill University.

Recent Publications

Oskoui, M, Dangouloff, T, Servais, L. Universal Newborn Screening for Spinal Muscular Atrophy. JAMA Pediatr. 2024. PMID:38587838

Marefi, A, Husein, N, Dunbar, M, Dewey, D, Letourneau, N, Oskoui, M et al.. Risk Factors for Term-Born Spastic Diplegic Cerebral Palsy: A Case-Control Study. Pediatr Neurol. 2024.155 26-32 PMID:38581726

Fehlings, DL, Zarrei, M, Engchuan, W, Sondheimer, N, Thiruvahindrapuram, B, MacDonald, JR et al.. Comprehensive whole-genome sequence analyses provide insights into the genomic architecture of cerebral palsy. Nat Genet. 2024.56 (4)585-594 PMID:38553553

Fortin, O, Husein, N, Oskoui, M, Shevell, MI, Kirton, A, Dunbar, M et al.. Risk Factors and Outcomes for Cerebral Palsy With Hypoxic-Ischemic Brain Injury Patterns Without Documented Neonatal Encephalopathy. Neurology. 2024.102 (6)e208111 PMID:38422458

Baranello, G, Neurodevelopment in SMA Working Group. The emerging spectrum of neurodevelopmental comorbidities in early-onset Spinal Muscular Atrophy. Eur J Paediatr Neurol. 2024.48 67-68 PMID:38043384

See more on PubMed